Retrospective Analysis of Hospital Medical Records on Medication and Supplement Use in Pregnant Women
NCT ID: NCT02842216
Last Updated: 2017-08-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1200 participants
OBSERVATIONAL
2016-07-31
2017-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Hospital medical records from all pregnant women who delivered between 01/07/2015 and 31/12/2015 in University Hospitals will be analyzed for the presence of medication and supplements.
Some demographic and obstetric parameters will be collected as well.
The anonymized dataset will be analyzed using descriptive statistics (Excel). There will be no intervention among the selected sample.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early PrEgnancy Complications Testing
NCT04079361
Genomic and Epigenomic Alterations After Cancer Treatment in Pregnancy
NCT04125446
Evaluation of the LMWH Thromboprophylaxis in Pregnancy
NCT01394107
Early Vascular Adjustments to Prevent Preeclampsia
NCT04216706
Evolution of Maternal Weight During Pregnancy and Influence on the Endothelial Function in Her Offspring
NCT02992106
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universitaire Ziekenhuizen KU Leuven
OTHER
KU Leuven
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michael Ceulemans
PhD Researcher
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MC201601
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.